HTATIP2 and laryngeal carcinoma: TIP30 has been found to be expressed in a wide variety of tumor tissues, including esophageal carcinoma [12], laryngeal carcinoma [13], glioma [14], pancreatic ductal adenocarcinoma [15], breast cancer [16], gastric cancer [17], gallbladder adenocarcinoma [18], lung cancer [19], and hepatocellular carcinoma [20].